Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Lipinski

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 4, 2019
Bridging to Surgery With Intravenous Platelet Inhibitors: Are We Treating the Patient or Ourselves?Michael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 2, 2020
Cardiogenic Shock in the Setting of Acute Myocardial Infarction: The Swinging Pendulum of RevascularizationMichael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2023
Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?Michael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 10, 2016
Natriuretic peptides in percutaneous coronary intervention: Aren't they all the same?Michael J Lipinski
Journal of the American College of Cardiology|September 13, 2014
The utility of thrombus aspiration for NSTEMI: déjà vu of aspiration for primary PCIRon Waksman, Michael J Lipinski
The New England Journal of Medicine|June 18, 2008
Drug-eluting stents vs. coronary-artery bypass graftingAntonio Abbate, Michael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 29, 2014
C-reactive protein prior to percutaneous coronary intervention: do we still need to check the lipid panel?Michael J Lipinski, Ron Waksman
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 7, 2006
Medical treatment of patients with heart failure or left ventricular dysfunction undergoing percutaneous coronary interventionMichael J Lipinski, George W Vetrovec
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 28, 2012
Kidneys outwit DES: round oneMichael J Lipinski, George W Vetrovec
Journal of Cardiovascular Pharmacology|March 26, 2014
Molecule 16673-34-0: a new tool in our arsenal against inflammationMichael J Lipinski, Juan C Frias
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 4, 2019
Bridging to Surgery With Intravenous Platelet Inhibitors: Are We Treating the Patient or Ourselves?Michael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 2, 2020
Cardiogenic Shock in the Setting of Acute Myocardial Infarction: The Swinging Pendulum of RevascularizationMichael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2023
Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?Michael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 10, 2016
Natriuretic peptides in percutaneous coronary intervention: Aren't they all the same?Michael J Lipinski
Journal of the American College of Cardiology|September 13, 2014
The utility of thrombus aspiration for NSTEMI: déjà vu of aspiration for primary PCIRon Waksman, Michael J Lipinski
The New England Journal of Medicine|June 18, 2008
Drug-eluting stents vs. coronary-artery bypass graftingAntonio Abbate, Michael J Lipinski
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 29, 2014
C-reactive protein prior to percutaneous coronary intervention: do we still need to check the lipid panel?Michael J Lipinski, Ron Waksman
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 7, 2006
Medical treatment of patients with heart failure or left ventricular dysfunction undergoing percutaneous coronary interventionMichael J Lipinski, George W Vetrovec
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 28, 2012
Kidneys outwit DES: round oneMichael J Lipinski, George W Vetrovec
Journal of Cardiovascular Pharmacology|March 26, 2014
Molecule 16673-34-0: a new tool in our arsenal against inflammationMichael J Lipinski, Juan C Frias
Pageof 13